GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B Turnover 46.55%
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$3.19B
AUM Growth
-$441M
Cap. Flow
-$728M
Cap. Flow %
-22.86%
Top 10 Hldgs %
67.11%
Holding
51
New
7
Increased
9
Reduced
27
Closed
6
Avg Time Held Equity + Options
2.3 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
2.3 years
Top 10 Avg Time Held Equity only
1.5 years
Top 20 Avg Time Held Equity only
1.8 years

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$12M
2
MDT icon
Medtronic
MDT
+$11.4M
3
MSFT icon
Microsoft
MSFT
+$11.3M
4
AMGN icon
Amgen
AMGN
+$11.2M
5
DOC icon
Healthpeak Properties
DOC
+$11.2M

Top Sells

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$76.5M
2
HCA icon
HCA Healthcare
HCA
+$64.2M
3
PARA icon
Paramount Global Class B
PARA
+$62.1M
4
DVA icon
DaVita
DVA
+$50.7M
5
FMC icon
FMC
FMC
+$48.4M

Sector Composition

Rank Sector Weight
1 Healthcare 74.27%
2 Technology 9.8%
3 Consumer Discretionary 6%
4 Materials 4.64%
5 Communication Services 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
THC icon
1
Tenet Healthcare
THC
$21.9B
$484M 15.2%
19,761,353
– –
2013 Q2
29 quarters
TAK icon
2
Takeda Pharmaceutical
TAK
$60.7B
$300M 9.4%
16,788,589
+593,279
+4% +$10.8M
2019 Q1
6 quarters
BHC icon
3
Bausch Health
BHC
$2.2B
$232M 7.3%
14,957,708
-686,420
-4% -$11.8M
2018 Q3
8 quarters
CI icon
4
Cigna
CI
$76.5B
$222M 6.97%
1,310,027
+8,277
+0.6% +$1.46M
2013 Q2
29 quarters
HCA icon
5
HCA Healthcare
HCA
$102B
$204M 6.41%
1,638,515
-518,694
-24% -$64.2M
2013 Q2
29 quarters
MCK icon
6
McKesson
MCK
$114B
$189M 5.92%
1,267,259
+48,555
+4% +$7.37M
2016 Q4
15 quarters
DXC icon
7
DXC Technology
DXC
$2.04B
$182M 5.73%
10,218,215
-1,769,815
-15% -$32.3M
2017 Q2
13 quarters
LH icon
8
Labcorp
LH
$25.7B
$131M 4.13%
812,986
-41,441
-5% -$6.57M
2020 Q2
1 quarter
HOLX icon
9
DELISTED
Hologic
HOLX
$96.4M 3.03%
1,450,171
-485,564
-25% -$30.7M
2018 Q2
9 quarters
PARA icon
10
DELISTED
Paramount Global Class B
PARA
$96.3M 3.02%
3,439,825
-2,316,959
-40% -$62.1M
2013 Q2
29 quarters
MTOR
11
DELISTED
MERITOR, Inc.
MTOR
$81.1M 2.54%
3,871,291
-1,580,189
-29% -$35.6M
2013 Q2
29 quarters
NUAN
12
DELISTED
Nuance Communications, Inc.
NUAN
$79.9M 2.51%
2,406,267
-2,635,864
-52% -$76.5M
2018 Q3
8 quarters
COR icon
13
Cencora
COR
$64.2B
$79.4M 2.49%
819,674
-135,485
-14% -$13.5M
2018 Q1
10 quarters
FMC icon
14
FMC
FMC
$1.26B
$73.6M 2.31%
694,509
-452,610
-39% -$48.4M
2015 Q1
22 quarters
IQV icon
15
IQVIA
IQV
$43.1B
$66M 2.07%
418,985
-132,273
-24% -$20.7M
2016 Q2
17 quarters
UHS icon
16
Universal Health Services
UHS
$11B
$61.6M 1.93%
575,634
-102,518
-15% -$11M
2016 Q3
16 quarters
CTVA icon
17
Corteva
CTVA
$8.94B
$48.1M 1.51%
1,670,774
-846,966
-34% -$23.8M
2019 Q4
3 quarters
MAR icon
18
Marriott International
MAR
$97B
$40.5M 1.27%
437,717
-284,172
-39% -$26.8M
2020 Q2
1 quarter
BSX icon
19
Boston Scientific
BSX
$62.3B
$39.9M 1.25%
1,045,052
-1,067,949
-51% -$41.2M
2020 Q1
2 quarters
MOH icon
20
Molina Healthcare
MOH
$10.9B
$38.1M 1.2%
208,374
-123,645
-37% -$22.5M
2020 Q1
2 quarters
MYGN icon
21
Myriad Genetics
MYGN
$397M
$36M 1.13%
2,757,993
+947,266
+52% +$12M
2019 Q3
4 quarters
CAR icon
22
Avis
CAR
$3.77B
$34.8M 1.09%
1,321,354
-954,055
-42% -$28.7M
2014 Q1
26 quarters
HUM icon
23
Humana
HUM
$51.3B
$34.4M 1.08%
83,089
-88,243
-52% -$35.5M
2018 Q4
7 quarters
BKD icon
24
Brookdale Senior Living
BKD
$2.41B
$32M 1%
12,586,554
-750,000
-6% -$2.07M
2014 Q2
25 quarters
EXPE icon
25
Expedia Group
EXPE
$33B
$31.7M 0.99%
345,433
+90,384
+35% +$8.13M
2020 Q2
1 quarter
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Glenview Capital Management held 51 positions worth $3.19B, down 12% from $3.63B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Glenview Capital Management withdrew a net $728M in Q3 2020, closing 6 positions and reducing 27 holdings. Its most notable exit was UnitedHealth, an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Medtronic worth $11.8M.

  • Glenview Capital Management's largest Q3 2020 buy was Medtronic: 113,882 shares worth $11.8M.
  • Glenview Capital Management added most to Myriad Genetics in Q3 2020, an estimated $12M increase.
  • Glenview Capital Management's biggest Q3 2020 reduction was Nuance Communications, Inc., cutting an estimated $76.5M.
  • Glenview Capital Management fully exited UnitedHealth in Q3 2020, selling an estimated $32.7M.
  • Glenview Capital Management's ten largest holdings make up 67% of its $3.19B portfolio in Q3 2020.
  • Glenview Capital Management opened 7 new positions and closed 6 in Q3 2020.
  • Glenview Capital Management's portfolio value fell 12% quarter-over-quarter to $3.19B.

Based on Glenview Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.